O	O	O	0	7	Central	Central	B-NP	JJ	B-cell_line	3	NMOD	B-cell_line
O	O	O	8	15	nervous	nervous	I-NP	JJ	I-cell_line	3	NMOD	I-cell_line
O	O	O	16	22	system	system	I-NP	NN	I-cell_line	6	NMOD	I-cell_line
O	O	O	22	23	-	-	B-NP	HYPH	I-cell_line	6	NMOD	I-cell_line
O	O	O	23	30	derived	derive	I-NP	VBN	I-cell_line	6	NMOD	I-cell_line
O	O	O	31	36	cells	cell	I-NP	NNS	I-cell_line	7	SUB	I-cell_line
O	O	O	37	44	express	express	B-VP	VBP	O	0	ROOT	O
O	O	O	45	46	a	a	B-NP	DT	O	10	NMOD	O
O	O	O	47	52	kappa	kappa	I-NP	NN	O	10	NMOD	O
O	O	O	53	54	B	B	I-NP	NN	O	13	NMOD	O
O	O	O	54	55	-	-	B-NP	HYPH	O	13	NMOD	O
O	O	O	55	62	binding	binding	I-NP	NN	O	13	NMOD	O
O	O	O	63	71	activity	activity	I-NP	NN	O	7	OBJ	O
O	O	O	72	76	that	that	B-NP	WDT	O	13	NMOD	O
O	O	O	77	85	enhances	enhance	B-VP	VBZ	O	14	SBAR	O
O	O	O	86	91	human	human	B-NP	JJ	O	21	NMOD	O
O	O	O	92	108	immunodeficiency	immunodeficiency	I-NP	NN	O	21	NMOD	O
O	O	O	109	114	virus	virus	I-NP	NN	O	21	NMOD	O
O	O	O	115	119	type	type	I-NP	NN	O	21	NMOD	O
O	O	O	120	121	1	1	I-NP	CD	O	21	NMOD	O
O	O	O	122	135	transcription	transcription	I-NP	NN	O	15	OBJ	O
O	O	O	136	138	in	in	B-ADVP	FW	O	15	VMOD	O
O	O	O	139	144	vitro	vitro	I-ADVP	FW	O	22	AMOD	O
O	O	O	145	148	and	and	O	CC	O	15	VMOD	O
O	O	O	149	160	facilitates	facilitate	B-VP	VBZ	O	15	VMOD	O
T8	B-Entity	B-Entity	161	164	TAR	TAR	B-NP	NN	B-DNA	29	NMOD	B-DNA
O	O	O	164	165	-	-	B-NP	HYPH	O	29	P	O
O	O	O	165	176	independent	independent	I-NP	JJ	O	29	NMOD	O
O	O	O	177	192	transactivation	transactivation	I-NP	NN	O	25	OBJ	O
O	O	O	193	195	by	by	B-PP	IN	O	29	NMOD	O
T1	B-Protein	B-Protein	196	199	Tat	Tat	B-NP	NN	B-protein	30	PMOD	B-protein
O	O	O	199	200	.	.	O	.	O	7	P	O

O	O	O	202	205	The	The	B-NP	DT	O	3	NMOD	O
T2	B-Protein	B-Protein	206	209	Tat	Tat	I-NP	NN	B-protein	3	NMOD	B-protein
O	O	O	210	217	protein	protein	I-NP	NN	I-protein	15	SUB	I-protein
O	O	O	218	220	of	of	B-PP	IN	O	3	NMOD	O
O	O	O	221	226	human	human	B-NP	JJ	O	8	NMOD	O
O	O	O	227	243	immunodeficiency	immunodeficiency	I-NP	NN	O	8	NMOD	O
O	O	O	244	249	virus	virus	I-NP	NN	O	8	NMOD	O
O	O	O	250	254	type	type	I-NP	NN	O	4	PMOD	O
O	O	O	255	256	1	1	I-NP	CD	O	8	NMOD	O
O	O	O	257	258	(	(	O	(	O	14	DEP	O
O	O	O	258	261	HIV	HIV	B-NP	NN	O	13	NMOD	O
O	O	O	261	262	-	-	B-NP	HYPH	O	13	P	O
O	O	O	262	263	1	1	I-NP	CD	O	14	DEP	O
O	O	O	263	264	)	)	O	)	O	8	NMOD	O
O	O	O	265	267	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	268	269	a	a	B-NP	DT	O	18	NMOD	O
O	O	O	270	276	potent	potent	I-NP	JJ	O	18	NMOD	O
O	O	O	277	286	activator	activator	I-NP	NN	O	25	NMOD	O
O	O	O	287	289	of	of	B-PP	IN	O	18	NMOD	O
T9	B-Entity	B-Entity	290	294	long	long	B-NP	JJ	B-DNA	22	NMOD	B-DNA
T9	I-Entity	I-Entity	295	303	terminal	terminal	I-NP	JJ	I-DNA	22	NMOD	I-DNA
T9	I-Entity	I-Entity	304	310	repeat	repeat	I-NP	NN	I-DNA	19	PMOD	I-DNA
O	O	O	310	311	-	-	B-VP	HYPH	O	25	NMOD	O
O	O	O	311	319	directed	direct	B-NP	VBN	O	25	NMOD	O
O	O	O	320	333	transcription	transcription	I-NP	NN	O	15	PRD	O
O	O	O	333	334	.	.	O	.	O	15	P	O

O	O	O	335	340	While	While	B-SBAR	IN	O	22	VMOD	O
O	O	O	341	343	in	in	B-PP	IN	O	8	VMOD	O
O	O	O	344	348	most	most	B-NP	JJS	O	5	NMOD	O
O	O	O	349	353	cell	cell	I-NP	NN	O	5	NMOD	O
O	O	O	354	359	types	type	I-NP	NNS	O	2	PMOD	O
O	O	O	359	360	,	,	O	,	O	8	P	O
O	O	O	361	371	activation	activation	B-NP	NN	O	8	SUB	O
O	O	O	372	380	requires	require	B-VP	VBZ	O	1	SBAR	O
O	O	O	381	392	interaction	interaction	B-NP	NN	O	8	OBJ	O
O	O	O	393	395	of	of	B-PP	IN	O	9	NMOD	O
T3	B-Protein	B-Protein	396	399	Tat	Tat	B-NP	NN	B-protein	10	PMOD	B-protein
O	O	O	400	404	with	with	B-PP	IN	O	9	NMOD	O
O	O	O	405	408	the	the	B-NP	DT	O	17	NMOD	O
O	O	O	409	416	unusual	unusual	I-NP	JJ	O	17	NMOD	O
T10	B-Entity	B-Entity	417	430	transcription	transcription	I-NP	NN	O	17	NMOD	O
T10	I-Entity	I-Entity	431	438	element	element	I-NP	NN	O	17	NMOD	O
T11	I-Entity	I-Entity	439	442	TAR	TAR	I-NP	NN	B-DNA	12	PMOD	B-DNA
O	O	O	442	443	,	,	O	,	O	22	P	O
O	O	O	444	454	astrocytic	astrocytic	B-NP	JJ	B-cell_type	21	NMOD	B-cell_type
O	O	O	455	460	glial	glial	I-NP	JJ	I-cell_type	21	NMOD	I-cell_type
O	O	O	461	466	cells	cell	I-NP	NNS	I-cell_type	22	SUB	I-cell_type
O	O	O	467	474	support	support	B-VP	VBP	O	0	ROOT	O
T12	B-Entity	B-Entity	475	478	TAR	TAR	B-NP	NN	B-DNA	26	NMOD	B-DNA
O	O	O	478	479	-	-	B-NP	HYPH	O	26	NMOD	O
O	O	O	479	490	independent	independent	I-NP	JJ	O	26	NMOD	O
O	O	O	491	506	transactivation	transactivation	I-NP	NN	O	22	OBJ	O
O	O	O	507	509	of	of	B-PP	IN	O	26	NMOD	O
O	O	O	510	513	HIV	HIV	B-NP	NN	O	31	NMOD	O
O	O	O	513	514	-	-	B-NP	HYPH	O	31	NMOD	O
O	O	O	514	515	1	1	I-NP	CD	O	31	NMOD	O
O	O	O	516	529	transcription	transcription	I-NP	NN	O	27	PMOD	O
O	O	O	530	532	by	by	B-PP	IN	O	26	NMOD	O
T4	B-Protein	B-Protein	533	536	Tat	Tat	B-NP	NN	B-protein	32	PMOD	B-protein
O	O	O	536	537	.	.	O	.	O	22	P	O

O	O	O	538	542	This	This	B-NP	DT	O	3	NMOD	O
O	O	O	543	554	alternative	alternative	I-NP	JJ	O	3	NMOD	O
O	O	O	555	562	pathway	pathway	I-NP	NN	O	7	SUB	O
O	O	O	563	565	of	of	B-PP	IN	O	3	NMOD	O
T5	B-Protein	B-Protein	566	569	Tat	Tat	B-NP	NN	B-protein	6	NMOD	B-protein
O	O	O	570	580	activation	activation	I-NP	NN	O	4	PMOD	O
O	O	O	581	583	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	584	592	mediated	mediate	I-VP	VBN	O	7	VC	O
O	O	O	593	595	by	by	B-PP	IN	O	8	VMOD	O
O	O	O	596	599	the	the	B-NP	DT	O	12	NMOD	O
T13	B-Entity	B-Entity	600	605	viral	viral	I-NP	JJ	B-DNA	12	NMOD	B-DNA
T13	I-Entity	I-Entity	606	614	enhancer	enhancer	I-NP	NN	I-DNA	17	NMOD	I-DNA
O	O	O	614	615	,	,	O	,	O	17	P	O
O	O	O	616	617	a	a	B-NP	DT	O	17	NMOD	O
T14	B-Entity	B-Entity	618	623	kappa	kappa	I-NP	NN	B-DNA	17	NMOD	B-DNA
T14	I-Entity	I-Entity	624	625	B	B	I-NP	NN	I-DNA	17	NMOD	I-DNA
T14	I-Entity	I-Entity	626	632	domain	domain	I-NP	NN	I-DNA	9	PMOD	I-DNA
O	O	O	633	640	capable	capable	B-ADJP	JJ	O	17	NMOD	O
O	O	O	641	643	of	of	B-PP	IN	O	18	AMOD	O
O	O	O	644	651	binding	bind	B-VP	VBG	O	19	PMOD	O
O	O	O	652	655	the	the	B-NP	DT	O	23	NMOD	O
O	O	O	656	668	prototypical	prototypical	I-NP	JJ	O	23	NMOD	O
O	O	O	669	673	form	form	I-NP	NN	O	20	OBJ	O
O	O	O	674	676	of	of	B-PP	IN	O	23	NMOD	O
O	O	O	677	680	the	the	B-NP	DT	O	31	NMOD	O
T15	B-Entity	B-Entity	681	694	transcription	transcription	I-NP	NN	B-protein	27	NMOD	B-protein
T15	I-Entity	I-Entity	695	701	factor	factor	I-NP	NN	I-protein	31	NMOD	I-protein
T15	I-Entity	I-Entity	702	709	nuclear	nuclear	B-NP	JJ	B-protein	31	NMOD	B-protein
T15	I-Entity	I-Entity	710	716	factor	factor	I-NP	NN	I-protein	31	NMOD	I-protein
T15	I-Entity	I-Entity	717	722	kappa	kappa	I-NP	NN	I-protein	31	NMOD	I-protein
T15	I-Entity	I-Entity	723	724	B	B	I-NP	NN	I-protein	24	PMOD	I-protein
O	O	O	725	726	(	(	O	(	O	37	DEP	O
T16	B-Entity	B-Entity	726	728	NF	NF	B-NP	NN	B-protein	36	NMOD	B-protein
T16	I-Entity	I-Entity	728	729	-	-	B-NP	HYPH	I-protein	36	NMOD	I-protein
T16	I-Entity	I-Entity	729	734	kappa	kappa	I-NP	NN	I-protein	36	NMOD	I-protein
T16	I-Entity	I-Entity	735	736	B	B	I-NP	NN	I-protein	37	DEP	I-protein
O	O	O	736	737	)	)	O	)	O	31	NMOD	O
O	O	O	738	745	present	present	B-ADJP	JJ	O	31	NMOD	O
O	O	O	746	748	in	in	B-PP	IN	O	38	AMOD	O
O	O	O	749	753	many	many	B-NP	JJ	O	42	NMOD	O
O	O	O	754	758	cell	cell	I-NP	NN	O	42	NMOD	O
O	O	O	759	764	types	type	I-NP	NNS	O	39	PMOD	O
O	O	O	764	765	,	,	O	,	O	42	P	O
O	O	O	766	775	including	include	B-PP	VBG	O	42	NMOD	O
O	O	O	776	777	T	T	B-NP	NN	B-cell_type	46	NMOD	B-cell_type
O	O	O	778	789	lymphocytes	lymphocyte	I-NP	NNS	I-cell_type	44	PMOD	I-cell_type
O	O	O	789	790	.	.	O	.	O	7	P	O

T6	B-Protein	B-Protein	791	794	Tat	Tat	B-NP	NN	B-protein	2	NMOD	B-protein
O	O	O	795	810	transactivation	transactivation	I-NP	NN	O	9	SUB	O
O	O	O	811	819	mediated	mediate	B-VP	VBN	O	2	NMOD	O
O	O	O	820	822	by	by	B-PP	IN	O	3	VMOD	O
O	O	O	823	826	the	the	B-NP	DT	O	8	NMOD	O
T17	B-Entity	B-Entity	827	832	kappa	kappa	I-NP	NN	B-DNA	8	NMOD	B-DNA
T17	I-Entity	I-Entity	833	834	B	B	I-NP	NN	I-DNA	8	NMOD	I-DNA
T17	I-Entity	I-Entity	835	841	domain	domain	I-NP	NN	I-DNA	4	PMOD	I-DNA
O	O	O	842	844	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	845	855	sufficient	sufficient	B-ADJP	JJ	O	9	PRD	O
O	O	O	856	858	to	to	B-VP	TO	O	12	VMOD	O
O	O	O	859	864	allow	allow	I-VP	VB	O	9	VMOD	O
O	O	O	865	876	replication	replication	B-NP	NN	O	17	AMOD	O
O	O	O	877	879	of	of	B-PP	IN	O	13	NMOD	O
T18	B-Entity	B-Entity	880	883	TAR	TAR	B-NP	NN	B-DNA	14	PMOD	B-DNA
O	O	O	883	884	-	-	O	HYPH	O	13	P	O
O	O	O	884	891	deleted	delete	B-VP	VBN	O	21	NMOD	O
O	O	O	892	898	mutant	mutant	B-NP	JJ	O	19	NMOD	O
O	O	O	899	902	HIV	HIV	I-NP	NN	O	21	NMOD	O
O	O	O	902	903	-	-	B-NP	HYPH	O	21	P	O
O	O	O	903	904	1	1	I-NP	CD	O	12	OBJ	O
O	O	O	905	907	in	in	B-PP	IN	O	21	NMOD	O
O	O	O	908	918	astrocytes	astrocyte	B-NP	NNS	B-cell_type	22	PMOD	B-cell_type
O	O	O	918	919	.	.	O	.	O	9	P	O

O	O	O	920	923	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	924	931	present	present	I-NP	JJ	O	3	NMOD	O
O	O	O	932	937	study	study	I-NP	NN	O	4	SUB	O
O	O	O	938	950	demonstrates	demonstrate	B-VP	VBZ	O	0	ROOT	O
O	O	O	951	954	the	the	B-NP	DT	O	6	NMOD	O
O	O	O	955	964	existence	existence	I-NP	NN	O	4	OBJ	O
O	O	O	965	967	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	968	973	kappa	kappa	B-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	974	975	B	B	I-NP	NN	I-protein	13	NMOD	I-protein
O	O	O	975	976	-	-	O	HYPH	I-protein	13	NMOD	I-protein
O	O	O	976	984	specific	specific	B-NP	JJ	I-protein	13	NMOD	I-protein
O	O	O	985	992	binding	bind	I-NP	VBG	I-protein	13	NMOD	I-protein
O	O	O	993	1000	factors	factor	I-NP	NNS	I-protein	7	PMOD	I-protein
O	O	O	1001	1008	present	present	B-ADJP	JJ	O	13	NMOD	O
O	O	O	1009	1011	in	in	B-PP	IN	O	14	AMOD	O
O	O	O	1012	1017	human	human	B-NP	JJ	B-cell_type	18	NMOD	B-cell_type
O	O	O	1018	1023	glial	glial	I-NP	JJ	I-cell_type	18	NMOD	I-cell_type
O	O	O	1024	1034	astrocytes	astrocyte	I-NP	NNS	I-cell_type	15	PMOD	I-cell_type
O	O	O	1035	1039	that	that	B-NP	WDT	O	18	NMOD	O
O	O	O	1040	1046	differ	differ	B-VP	VBP	O	19	SBAR	O
O	O	O	1047	1051	from	from	B-PP	IN	O	20	VMOD	O
O	O	O	1052	1064	prototypical	prototypical	B-NP	JJ	O	26	NMOD	O
T19	B-Entity	B-Entity	1065	1067	NF	NF	I-NP	NN	B-protein	26	NMOD	B-protein
T19	I-Entity	I-Entity	1067	1068	-	-	B-NP	HYPH	I-protein	26	NMOD	I-protein
T19	I-Entity	I-Entity	1068	1073	kappa	kappa	I-NP	NN	I-protein	26	NMOD	I-protein
T19	I-Entity	I-Entity	1074	1075	B	B	I-NP	NN	I-protein	21	PMOD	I-protein
O	O	O	1075	1076	.	.	O	.	O	4	P	O

O	O	O	1077	1080	The	The	B-NP	DT	O	3	NMOD	O
O	O	O	1081	1086	novel	novel	I-NP	JJ	O	3	NMOD	O
O	O	O	1087	1096	astrocyte	astrocyte	I-NP	NN	O	10	NMOD	O
O	O	O	1096	1097	-	-	B-VP	HYPH	O	10	NMOD	O
O	O	O	1097	1104	derived	derive	B-NP	VBN	O	10	NMOD	O
O	O	O	1105	1110	kappa	kappa	I-NP	NN	O	10	NMOD	O
O	O	O	1111	1112	B	B	I-NP	NN	O	10	NMOD	O
O	O	O	1112	1113	-	-	B-NP	HYPH	O	10	NMOD	O
O	O	O	1113	1120	binding	binding	I-NP	NN	O	10	NMOD	O
O	O	O	1121	1129	activity	activity	I-NP	NN	O	11	SUB	O
O	O	O	1130	1132	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1133	1141	retained	retain	I-VP	VBN	O	11	VC	O
O	O	O	1142	1144	on	on	B-PP	IN	O	12	VMOD	O
O	O	O	1145	1147	an	an	B-NP	DT	O	20	NMOD	O
O	O	O	1148	1151	HIV	HIV	I-NP	NN	B-protein	20	NMOD	B-protein
O	O	O	1151	1152	-	-	B-NP	HYPH	I-protein	20	NMOD	I-protein
O	O	O	1152	1153	1	1	I-NP	CD	I-protein	20	NMOD	I-protein
T7	B-Protein	B-Protein	1154	1157	Tat	Tat	I-NP	NN	I-protein	20	NMOD	I-protein
O	O	O	1158	1166	affinity	affinity	I-NP	NN	O	20	NMOD	O
O	O	O	1167	1173	column	column	I-NP	NN	O	13	PMOD	O
O	O	O	1173	1174	,	,	O	,	O	11	P	O
O	O	O	1175	1180	while	while	B-SBAR	IN	O	11	VMOD	O
O	O	O	1181	1193	prototypical	prototypical	B-NP	JJ	O	27	NMOD	O
T20	B-Entity	B-Entity	1194	1196	NF	NF	I-NP	NN	B-protein	27	NMOD	B-protein
T20	I-Entity	I-Entity	1196	1197	-	-	B-NP	HYPH	I-protein	27	NMOD	I-protein
T20	I-Entity	I-Entity	1197	1202	kappa	kappa	I-NP	NN	I-protein	27	NMOD	I-protein
T20	I-Entity	I-Entity	1203	1204	B	B	I-NP	NN	I-protein	32	SUB	I-protein
O	O	O	1205	1209	from	from	B-PP	IN	O	27	NMOD	O
O	O	O	1210	1216	Jurkat	Jurkat	B-NP	NN	B-cell_line	31	NMOD	B-cell_line
O	O	O	1217	1218	T	T	I-NP	NN	I-cell_line	31	NMOD	I-cell_line
O	O	O	1219	1224	cells	cell	I-NP	NNS	I-cell_line	28	PMOD	I-cell_line
O	O	O	1225	1227	is	be	B-VP	VBZ	O	22	SBAR	O
O	O	O	1228	1231	not	not	O	RB	O	32	VMOD	O
O	O	O	1231	1232	.	.	O	.	O	11	P	O

O	O	O	1233	1235	In	In	B-NP	FW	O	2	AMOD	O
O	O	O	1236	1241	vitro	vitro	I-NP	FW	O	4	NMOD	O
O	O	O	1242	1255	transcription	transcription	I-NP	NN	O	4	NMOD	O
O	O	O	1256	1263	studies	study	I-NP	NNS	O	5	SUB	O
O	O	O	1264	1275	demonstrate	demonstrate	B-VP	VBP	O	0	ROOT	O
O	O	O	1276	1280	that	that	B-SBAR	IN	O	5	VMOD	O
O	O	O	1281	1290	astrocyte	astrocyte	B-NP	NN	B-cell_type	6	SBAR	B-cell_type
O	O	O	1290	1291	-	-	B-VP	HYPH	O	7	NMOD	O
O	O	O	1291	1298	derived	derive	B-NP	VBN	O	8	SBAR	O
O	O	O	1299	1304	kappa	kappa	I-NP	NN	O	11	NMOD	O
O	O	O	1305	1306	B	B	I-NP	NN	O	15	SUB	O
O	O	O	1306	1307	-	-	B-VP	HYPH	O	11	NMOD	O
O	O	O	1307	1314	binding	bind	B-NP	VBG	B-protein	14	NMOD	B-protein
O	O	O	1315	1322	factors	factor	I-NP	NNS	I-protein	12	OBJ	I-protein
O	O	O	1323	1331	activate	activate	B-VP	VBP	O	9	VMOD	O
O	O	O	1332	1345	transcription	transcription	B-NP	NN	O	15	OBJ	O
O	O	O	1346	1348	of	of	B-PP	IN	O	16	NMOD	O
O	O	O	1349	1352	the	the	B-NP	DT	O	24	NMOD	O
T21	B-Entity	B-Entity	1353	1356	HIV	HIV	I-NP	NN	B-DNA	24	NMOD	B-DNA
T21	I-Entity	I-Entity	1356	1357	-	-	B-NP	HYPH	I-DNA	24	NMOD	I-DNA
T21	I-Entity	I-Entity	1357	1358	1	1	I-NP	CD	I-DNA	24	NMOD	I-DNA
T21	I-Entity	I-Entity	1359	1363	long	long	I-NP	JJ	I-DNA	24	NMOD	I-DNA
T21	I-Entity	I-Entity	1364	1372	terminal	terminal	I-NP	JJ	I-DNA	24	NMOD	I-DNA
T21	I-Entity	I-Entity	1373	1379	repeat	repeat	I-NP	NN	I-DNA	17	PMOD	I-DNA
O	O	O	1380	1383	and	and	O	CC	O	15	VMOD	O
O	O	O	1384	1388	that	that	B-SBAR	IN	O	15	VMOD	O
O	O	O	1389	1393	this	this	B-NP	DT	O	28	NMOD	O
O	O	O	1394	1404	activation	activation	I-NP	NN	O	29	SUB	O
O	O	O	1405	1407	is	be	B-VP	VBZ	O	26	SBAR	O
O	O	O	1408	1417	dependent	dependent	B-ADJP	JJ	O	29	PRD	O
O	O	O	1418	1420	on	on	B-PP	IN	O	30	AMOD	O
O	O	O	1421	1424	the	the	B-NP	DT	O	35	NMOD	O
T22	B-Entity	B-Entity	1425	1430	kappa	kappa	I-NP	NN	B-DNA	35	NMOD	B-DNA
T22	I-Entity	I-Entity	1431	1432	B	B	I-NP	NN	I-DNA	35	NMOD	I-DNA
T22	I-Entity	I-Entity	1433	1439	domain	domain	I-NP	NN	I-DNA	31	PMOD	I-DNA
O	O	O	1439	1440	.	.	O	.	O	5	P	O

O	O	O	1441	1449	Moreover	Moreover	B-ADVP	RB	O	12	VMOD	O
O	O	O	1449	1450	,	,	O	,	O	12	P	O
T23	B-Entity	B-Entity	1451	1454	TAR	TAR	B-NP	NN	B-DNA	6	NMOD	B-DNA
O	O	O	1454	1455	-	-	B-NP	HYPH	O	6	P	O
O	O	O	1455	1466	independent	independent	I-NP	JJ	O	6	NMOD	O
O	O	O	1467	1482	transactivation	transactivation	I-NP	NN	O	12	SUB	O
O	O	O	1483	1485	of	of	B-PP	IN	O	6	NMOD	O
O	O	O	1486	1489	HIV	HIV	B-NP	NN	O	11	NMOD	O
O	O	O	1489	1490	-	-	B-NP	HYPH	O	11	NMOD	O
O	O	O	1490	1491	1	1	I-NP	CD	O	11	NMOD	O
O	O	O	1492	1505	transcription	transcription	I-NP	NN	O	7	PMOD	O
O	O	O	1506	1508	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1509	1519	reproduced	reproduce	I-VP	VBN	O	12	VC	O
O	O	O	1520	1522	in	in	B-ADVP	FW	O	13	VMOD	O
O	O	O	1523	1528	vitro	vitro	I-ADVP	FW	O	14	AMOD	O
O	O	O	1529	1531	in	in	B-PP	IN	O	13	VMOD	O
O	O	O	1532	1534	an	an	B-NP	DT	O	19	NMOD	O
O	O	O	1535	1544	astrocyte	astrocyte	I-NP	NN	B-protein	19	NMOD	B-protein
O	O	O	1545	1551	factor	factor	I-NP	NN	I-protein	22	NMOD	I-protein
O	O	O	1551	1552	-	-	B-NP	HYPH	O	22	P	O
O	O	O	1552	1561	dependent	dependent	I-NP	JJ	O	22	NMOD	O
O	O	O	1562	1568	manner	manner	I-NP	NN	O	16	PMOD	O
O	O	O	1569	1574	which	which	B-NP	WDT	O	22	NMOD	O
O	O	O	1575	1585	correlates	correlate	B-VP	VBZ	O	23	SBAR	O
O	O	O	1586	1590	with	with	B-PP	IN	O	24	VMOD	O
O	O	O	1591	1596	kappa	kappa	B-NP	NN	B-protein	27	NMOD	B-protein
O	O	O	1597	1598	B	B	I-NP	NN	I-protein	30	NMOD	I-protein
O	O	O	1598	1599	-	-	B-NP	HYPH	O	30	NMOD	O
O	O	O	1599	1606	binding	binding	I-NP	NN	O	30	NMOD	O
O	O	O	1607	1615	activity	activity	I-NP	NN	O	25	PMOD	O
O	O	O	1615	1616	.	.	O	.	O	12	P	O

O	O	O	1617	1620	The	The	B-NP	DT	O	2	NMOD	O
O	O	O	1621	1631	importance	importance	I-NP	NN	O	22	SUB	O
O	O	O	1632	1634	of	of	B-PP	IN	O	2	NMOD	O
O	O	O	1635	1638	the	the	B-NP	DT	O	7	NMOD	O
O	O	O	1639	1646	central	central	I-NP	JJ	O	7	NMOD	O
O	O	O	1647	1654	nervous	nervous	I-NP	JJ	O	7	NMOD	O
O	O	O	1655	1661	system	system	I-NP	NN	O	3	PMOD	O
O	O	O	1661	1662	-	-	B-VP	HYPH	O	7	NMOD	O
O	O	O	1662	1670	enriched	enrich	B-NP	VBN	O	13	NMOD	O
O	O	O	1671	1676	kappa	kappa	I-NP	NN	O	13	NMOD	O
O	O	O	1677	1678	B	B	I-NP	NN	O	13	NMOD	O
O	O	O	1679	1692	transcription	transcription	I-NP	NN	B-protein	13	NMOD	B-protein
O	O	O	1693	1699	factor	factor	I-NP	NN	I-protein	8	PMOD	I-protein
O	O	O	1700	1702	in	in	B-PP	IN	O	13	NMOD	O
O	O	O	1703	1706	the	the	B-NP	DT	O	16	NMOD	O
O	O	O	1707	1717	regulation	regulation	I-NP	NN	O	14	PMOD	O
O	O	O	1718	1720	of	of	B-PP	IN	O	16	NMOD	O
T24	B-Entity	B-Entity	1721	1724	HIV	HIV	B-NP	NN	O	21	NMOD	O
T24	I-Entity	I-Entity	1724	1725	-	-	B-NP	HYPH	O	21	NMOD	O
T24	I-Entity	I-Entity	1725	1726	1	1	I-NP	CD	O	21	NMOD	O
O	O	O	1727	1737	expression	expression	I-NP	NN	O	17	PMOD	O
O	O	O	1738	1740	is	be	B-VP	VBZ	O	0	ROOT	O
O	O	O	1741	1750	discussed	discuss	I-VP	VBN	O	22	VC	O
O	O	O	1750	1751	.	.	O	.	O	22	P	O
